Related Experiment Videos
[Treatment of neonatal jaundice by efficient phototherapy]
Insights
Phototherapy is the preferred treatment for idiopathic neonatal jaundice, effectively reducing bilirubin levels by converting it into a water-soluble form. Optimal phototherapy involves timely initiation, short durations, and maximizing light exposure for infants.
Area of Science:
- Neonatal Medicine
- Biochemistry
- Photobiology
Context:
- Idiopathic neonatal jaundice stems from immature bilirubin metabolism in newborns.
- Neonatal hyperbilirubinemia necessitates treatment when there's a risk of bilirubin intoxication, considering infant maturity and clinical status.
Purpose:
- To evaluate phototherapy as the primary treatment for idiopathic neonatal hyperbilirubinemia.
- To define optimal parameters for phototherapy administration based on its efficacy.
Summary:
- Phototherapy bypasses immature hepatic enzyme systems by using light (around 460 nm) to convert hydrophobic bilirubin into a water-soluble isomer excreted by the kidneys.
- The reduction in serum bilirubin concentration under phototherapy follows an exponential function, informing treatment protocols.
- Effective phototherapy requires appropriate timing, minimized duration, maximized surface area exposure, and optimized light source utilization.
Impact:
- Establishes phototherapy as the treatment of choice for neonatal jaundice, offering a safe and effective alternative to transfusion or enzyme induction.
- Provides evidence-based guidelines for optimizing phototherapy, enhancing treatment efficacy and safety.
- Highlights the importance of considering infant-specific factors in managing neonatal hyperbilirubinemia.
Abstract:
Idiopathic neonatal jaundice derives from an initial insufficiency of all processes which metabolize hydrophobic bilirubin into diglucuronide excretable in bile. The term 'neonatal hyperbilirubinemia' should only be used when there is a potential risk of bilirubin intoxication. Thus, the concept hyperbilirubinemia is not necessarily linked to the exceeding of a certain threshold value, but rather to the maturity of the child and its clinical condition. In this sense, hyperbilirubinemia is, therefore, always a syndrome requiring treatment. Besides substitution transfusion, which is highly effective per se, but risky and costly, enzyme induction (e.g., by administration of phenobarbital) represents an elegant causal therapy; however, because of its slow onset of action, it has to be given prophylactically to almost all newborns. In addition, this method requires a general induction of all microsomal enzyme systems, and is hence a major intervention in the process of maturation of the neonatal enzyme systems. Therefore, phototherapy must be regarded as the treatment of choice in cases of idiopathic neonatal hyperbilirubinemia. It leads to a bypassing of the hepatic enzyme insufficiency in that by interaction between light with a wavelength of around 460 nm and the bilirubin molecules in the skin, an isomeric, water-soluble, renally secretable bilirubin is produced. The effect of phototherapy, i.e., the reduction in the serum bilirubin concentration under phototherapy, may be described as a simple e-function. The evaluation of this regular occurrence provides important information applicable to the phototherapy procedure: it should not be initiated prematurely, the duration of radiation should be as short as possible, the irradiated surface as large as possible, the radiation source should be exploited to a maximum by keeping the distance from the light source short and using lateral reflectors. As supporting measures intestinal lavage, early oral administration of dextrose or oligosaccharide solution and possibly in some cases also human albumin are very useful.